Innovations in Molecular Diagnostics for Infectious Diseases

This report examines the opportunities presented to the developers of molecular diagnostics by the emergence of novel/variant pathogens and ways in which new molecular testing technologies are being translated into superior diagnostic products in areas such as healthcare-associated infections; HPV infections, blood-borne viral infections and respiratory viral infections.

The latest molecular diagnostics to enter development are multiplex tests which can identify several pathogens or variants of these pathogens present in small-volume samples. Low- and medium-density bead-based microarrays are being developed and are expected to play an increasingly important role in multiplex pathogen detection and genotyping.

It is likely that future diagnostic tests will target many more pathogens than is currently the case. Promising approaches include miniaturized microfluidic systems, in particular continuous-flow droplet-based PCR systems, and mass spectrometry-based detection methods which use direct specimen testing and virtually no reagents.

Growth forecasts are derived for key MDx market segments for the period 2010-2015: the HPV testing market is forecast to grow with a 5-year CAGR of 20%, the hospital-associated infection (HAI) testing market is forecast to grow with a 5-year CAGR of 19%. and the virology (HIV/HCV/HBV) testing market is forecast to grow with a 5-year CAGR of 8%.

Read more...

Comments

Add New Search RSS

Write comment
Name:
Email:	do not notifynotify
Website:
Title:
	Please input the anti-spam code that you can read in the image.

Powered by !JoomlaComment 3.26

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

• Respiratory viral infections (10/06/2010)
• Medicinal Utility of Some Herbs in Veterinary Practices (21/09/2009)
• Tuberculosis (03/04/2009)

• Orphan Drug (17/09/2012)
• Drug Delivery Partnership (18/06/2012)
• Global CT Market (18/06/2012)

• Biomarkers in Alzheimer's Disease (18/06/2012)
• Global Generics (16/11/2011)
• Generics in Japan (16/11/2011)
• Global Health Care Equipment (16/11/2011)
• OTC (25/07/2011)
• mHealth and Telemedicine (06/07/2011)
• Epilepsy (01/07/2011)
• Epilepsy (01/07/2011)
• Epilepsy (01/07/2011)

---